Perception of disease severity in patients with multiple sclerosis

被引:0
|
作者
Leon, I. [1 ]
Bau, L. [1 ]
Matas, E. [1 ]
Romero-Pinel, L. [1 ]
Mane-Martinez, M. A. [2 ]
Macho, S. [1 ]
Martinez-Yelamos, A. [1 ]
Martinez-Yelamos, S. [1 ]
机构
[1] Hosp Univ Bellvitge, IDIBELL, Dept Neurol, Lhospitalet De Llobregat, Spain
[2] Univ Rovira & Virgili, Hosp Univ Joan 23, Dept Neurol, Tarragona, Spain
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P775
引用
收藏
页码:386 / 387
页数:2
相关论文
共 50 条
  • [31] Season of birth is associated with multiple sclerosis and disease severity
    Stridh, P.
    Huang, J.
    Hedstrom, A. K.
    Alfredsson, L.
    Olsson, T.
    Hillert, J.
    Manouchehrinia, A.
    Kockum, I
    [J]. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (04)
  • [32] Cardiopulmonary fitness is related to disease severity in multiple sclerosis
    Heine, Martin
    Wens, Inez
    Langeskov-Christensen, Martin
    Verschuren, Olaf
    Eijnde, Bert O.
    Kwakkel, Gert
    Dalgas, Ulrik
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (02) : 231 - 238
  • [33] Kappa index as a biomarker for disease severity in multiple sclerosis
    Menendez-Valladares, P.
    Garcia-Sanchez, M. I.
    Bermudo-Guitarte, C.
    [J]. CLINICA CHIMICA ACTA, 2019, 493 : S615 - S616
  • [34] Serum GFAP as a biomarker for disease severity in multiple sclerosis
    A. Abdelhak
    A. Huss
    J. Kassubek
    H. Tumani
    M. Otto
    [J]. Scientific Reports, 8
  • [35] sRAGE: A potential biomarker of multiple sclerosis disease severity
    Sternberg, Zohara
    Weinstock-Guttman, Bianca
    Chadha, Kailash
    Lieberman, Alicia
    Hojnacki, David
    Zamboni, Paolo
    Zivadinov, Robert
    Kazim, Latif
    Drake, Allison S.
    Grazioli, Erica
    Munschauer, Frederick E.
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S245 - S245
  • [36] Constructing a Molecular Model of Disease Severity in Multiple Sclerosis
    Barbour, Christopher R.
    Kosa, Peter
    Greenwood, Mark
    Bielekova, Bibiana
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 23 - 23
  • [37] Serum GFAP as a biomarker for disease severity in multiple sclerosis
    Abdelhak, A.
    Huss, A.
    Kassubek, J.
    Tumani, H.
    Otto, M.
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [38] Genes and outcomes in multiple sclerosis: predicting disease severity
    Ebers, George
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S19 - S19
  • [39] Assessment of disease severity in early multiple sclerosis.
    Scott, TF
    Novero, J
    Chieffe, C
    [J]. ANNALS OF NEUROLOGY, 1999, 46 (03) : 473 - 473
  • [40] Effect of fingolimod on multiple sclerosis severity score (MSSS) in patients with relapsing multiple sclerosis
    Montalban, X.
    Reder, A. T.
    Cohen, J.
    Ritter, S.
    Tomic, D.
    Meier, D. Piani
    Kappos, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 645 - 645